MRx0029
INNOVATE-LBP 1.0
Phase 1 mab terminated
Quick answer
MRx0029 for Idiopathic Parkinson Disease is a Phase 1 program (mab) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- Idiopathic Parkinson Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated